Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

Aevi Genomic Medicine Inc (NASDAQ:GNMX.DL)

CAPS Rating: No stars

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:GNMX.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (98.68)
Submitted March 21, 2013

I'm as skeptical as anyone about the long-term prospects of Medgenics. For a technology as groundbreaking as the Biopump would seem to be, there doesn't seem to be much excitement coming from anyone except management. And if the company does indeed… More

zzlangerhans (98.68)
Submitted January 10, 2014

Medgenics is making slow progress with their rather dubious Biopump platform. Enrollment has begun in the phase I/II trial of Infradure for hepatitis C in Israel, but interim data doesn't seem to have appeared in late 2013 as promised. And really,… More

NASDAQ:GNMX.DL VS S&P 500 (SPY)

NASDAQ:GNMX.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about GNMX.DL.

No one has written a Pitch for GNMX.DL stock yet. Tell us why you think GNMX.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in GNMX.DL.

No players have picked GNMX.DL yet. Tell us why you think GNMX.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for GNMX.DL.